You searched for "market"
Does Koos classification predict facial nerve dysfunction?
The Koos classification is a grading system used often for preoperative evaluation of acoustic tumours on imaging studies. It indirectly correlates to the size of the tumour. Size of the vestibular schwannoma is often considered the main determinant for hearing...
Canal wall up mastoid defects - can they be usefully reconstructed with hydroxyapatite cranioplastic cement?
Standard canal wall up (CWU) mastoid surgery leaves a mastoid defect of varying size, commonly covered by soft tissue. Rarely, this bony defect can cause discomfort, cosmetic issues or other problems. To mitigate these, the defect can be filled either...
COVID-19 in patients with chronic rhinosinusitis with polyps. Are they at risk?
COVID-19 entry factors are highly present in nasal epithelial cells. These factors include ACE2 and TMPRSS2. Their presence in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) was not investigated before. Authors investigated expression of ACE2 and TMPRSS2 in two...
Audiology and COVID-19
COVID-19 affected all clinical services in a very short time, including audiology. This service improvement investigation concentrated on how audiology services in the UK were impacted by the virus and how perception of tele-audiology changed. About 120 practising audiologists were...
Core biopsies are good enough for lymphomas
This paper, from the South of England, has reviewed ultrasound-guided core needle biopsies over a six-year period investigating the use of the detection of head and neck lymphomas. There were 367 samples included from 226 patients; 215 of the 226...
Long-term curative effects of microvascular decompression for hemifacial spasm
This article describes results of a multicentre prospective trial performed to evaluate long- and short-term outcomes and complications of patients who underwent microvascular decompression (MVD) for hemifacial spasm (HFS). The surgeries were performed by surgeons with more than 15 years...
Can we predict how much benefit patients will get from ESS with a novel monoclonal antibody
Mepolizumab (Nucala) is a humanised IgG1 monoclonal antibody that acts as an IL-5 antagonist. It has been shown to be highly effective in treating severe asthma. It is hypothesised that it will be effective for patients with recalcitrant CRSwNP. This...
Structures determining T4a, T4b
This paper for tertiary cancer centre in India attempted to determine whether patients with T4b oral cancers involving the 'masticator space' should be treated with survival intent comparable to T4a cancers. Over a 7-year period, 30 patients with T4b cancers...
Till death do us part: the role of the speech and language therapists in palliative care
Increasingly, speech and language therapists are being involved in end-of-life and palliative care. This study reports on a three-phase project to explore this in the context of the Australian healthcare system. In phase one, the authors described a scoping review...
Review of pituitary tumour pathology
This is an excellent review article covering the pathology of pituitary adenomas (PA) as well as rare sellar lesions like lymphocytic hypophysitis that require aggressive treatment. The authors have preserved the 2017 World Health Organization (WHO) classification of PA and...
Bone bridge conduction device for patients with bilateral microtia-atresia.
Management of microtia-atresia requires a multidisciplinary approach. Children normally require bone conduction hearing aid devices very early in life to improve and facilitate speech and language development. At a later stage, when the cranial bones have strengthened and become thicker,...
